Advantages and disadvantages of antimicrobial prophylaxis in chronic granulomatous disease of childhood.
Gonzalez
L A
LA
Department of Pediatrics, University of Utah, Salt Lake City 84132.
Hill
H R
HR
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D002648:Child; D004338:Drug Combinations / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006105:Granulomatous Disease, Chronic / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D013419:Sulfamethizole / Q000627:therapeutic use*; D013432:Sulfathiazoles / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D000096926:Benzenesulfonamides
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D013419:Sulfamethizole; D013432:Sulfathiazoles; D014295:Trimethoprim; C029078:trimethoprim sulfamethizole; D000096926:Benzenesulfonamides